284 related articles for article (PubMed ID: 19027855)
1. Characterization of the vitamin D endocrine system in human sebocytes in vitro.
Krämer C; Seltmann H; Seifert M; Tilgen W; Zouboulis CC; Reichrath J
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):9-16. PubMed ID: 19027855
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.
Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E
Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850
[TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
[TBL] [Abstract][Full Text] [Related]
5. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3659-67. PubMed ID: 19667162
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the vitamin D system in basal cell carcinomas (BCCs).
Mitschele T; Diesel B; Friedrich M; Meineke V; Maas RM; Gärtner BC; Kamradt J; Meese E; Tilgen W; Reichrath J
Lab Invest; 2004 Jun; 84(6):693-702. PubMed ID: 15077124
[TBL] [Abstract][Full Text] [Related]
7. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
Segersten U; Björklund P; Hellman P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
[TBL] [Abstract][Full Text] [Related]
8. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system.
Viganò P; Lattuada D; Mangioni S; Ermellino L; Vignali M; Caporizzo E; Panina-Bordignon P; Besozzi M; Di Blasio AM
J Mol Endocrinol; 2006 Jun; 36(3):415-24. PubMed ID: 16720713
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer.
Friedrich M; Rafi L; Mitschele T; Tilgen W; Schmidt W; Reichrath J
Recent Results Cancer Res; 2003; 164():239-46. PubMed ID: 12899526
[TBL] [Abstract][Full Text] [Related]
10. Particulate matter 2.5 regulates lipid synthesis and inflammatory cytokine production in human SZ95 sebocytes.
Liu Q; Wu J; Song J; Liang P; Zheng K; Xiao G; Liu L; Zouboulis CC; Lei T
Int J Mol Med; 2017 Oct; 40(4):1029-1036. PubMed ID: 28849137
[TBL] [Abstract][Full Text] [Related]
11. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.
Verone-Boyle AR; Shoemaker S; Attwood K; Morrison CD; Makowski AJ; Battaglia S; Hershberger PA
Oncotarget; 2016 Jan; 7(1):995-1013. PubMed ID: 26654942
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the vitamin D system in cutaneous squamous cell carcinomas.
Reichrath J; Rafi L; Rech M; Mitschele T; Meineke V; Gärtner BC; Tilgen W; Holick MF
J Cutan Pathol; 2004 Mar; 31(3):224-31. PubMed ID: 14984574
[TBL] [Abstract][Full Text] [Related]
13. Regulation of stearoyl-coenzyme A desaturase and fatty acid delta-6 desaturase-2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis.
Zouboulis CC; Angres S; Seltmann H
Br J Dermatol; 2011 Aug; 165(2):269-76. PubMed ID: 21457203
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
15. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
16. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
[TBL] [Abstract][Full Text] [Related]
18. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.
Reichrath J; Zouboulis CC; Vogt T; Holick MF
Rev Endocr Metab Disord; 2016 Sep; 17(3):405-417. PubMed ID: 27447175
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D--metabolism in the human breast cancer cell line MCF-7.
Diesing D; Cordes T; Fischer D; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(4A):2755-9. PubMed ID: 16886688
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor and 1alpha,25-dihydroxyvitamin D3 suppress lipogenesis in hamster sebaceous gland cells in vitro.
Sato T; Imai N; Akimoto N; Sakiguchi T; Kitamura K; Ito A
J Invest Dermatol; 2001 Oct; 117(4):965-70. PubMed ID: 11676839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
